Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous <i>DARS2</i> mutation: Figure 1
Matthis Synofzik(German Center for Neurodegenerative Diseases), Lüdger Schöls(German Center for Neurodegenerative Diseases), Tobias Lindig(University Children's Hospital Tübingen), Jochen Hansel(HNO-Praxis), Saskia Biskup(Praxis für Humangenetik Tübingen), Thorsten Schmidt(University of Tübingen), F. Lehmann‐Horn(Universität Ulm), Julia Schicks(German Center for Neurodegenerative Diseases)
Cited by 49
Related Papers
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
|The Lancet Neurology|2004|1.1k
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7
|Progress in Neurobiology|2013|360
Transgenic rat model of Huntington's disease
|Human Molecular Genetics|2003|349
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1
|Nature Genetics|2002|319
Nitric Oxide Destroys Zinc-Sulfur Clusters Inducing Zinc Release from Metallothionein and Inhibition of the Zinc Finger-Type Yeast Transcription Activator LAC9
|Biochemical and Biophysical Research Communications|1994|278